Karyopharm Therapeutics Inc. (KPTI) NASDAQ
8.85
-0.065(-0.73%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
8.85
-0.065(-0.73%)
Currency In USD
| Market Cap | 80.48M |
| Enterprise Value | 253.55M |
| P/E Ratio | -0.81 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 0.52 |
| Price/Book Ratio | -0.54 |
| Enterprise/Revenue | 1.7 |
| Enterprise/EBITDA | -3.16 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -1.34 |
| Operating Margin | -0.62 |
| Return On Assets | -1.81 |
| Return On Equity | 0.78 |
| Revenue | 146.07M |
| Revenue/Share | 8.13 |
| Gross Profit | 140.12M |
| EBITDA | -90.41M |
| Net Income | -196.04M |
| Diluted EPS | -17.93 |
| Total Cash | 63.74M |
| Total Cash/Share | 3.55 |
| Total Debt | 233.61M |
| Total Debt/Equity | -0.8 |
| Current Ratio | 1.12 |
| Book Value Per Share | -16.3 |
| 52-Week Change | 79.88 |
| 52-Week High | 10.99 |
| 52-Week Low | 3.65 |
| Moving Average 50 Days | 7.97 |
| Moving Average 200 Days | 6.84 |
| Average Volume | 936,740 |
| Shares Outstanding | 8.54M |
| % Held by Institutions | 52.66 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | February 26, 2025 |